All the news Showing 9 of 819 articles from: Health services, policy and advocacyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Republic of Georgia plagued by hepatitis C Vaccine News Daily / 20 February 2013 Have a heart, save my liver! HepCoalition.org / 14 February 2013 Support Inclusion of Pegylated Interferon in the World Health Organization’s Essential Medicines List Treatment Action Group / 23 January 2013 Hepatitis C: A projection of the healthcare and economic burden in the UK RAND Corporation / 15 January 2013 Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic Michael Carter / 09 January 2013 “Persistent HBV [hepatitis B virus] infection has changed its face in the UK,” research published in the online edition of Clinical Infectious Diseases shows. The study found considerable diversity in viral genotype and ... Which patients should be prioritised for new hepatitis C treatments? Rob Camp / 23 November 2012 Younger patients with advanced liver disease caused by hepatitis C should be prioritised for treatment with newly licensed directly acting antivirals to achieve the biggest reductions in ill health and hospitalisation, according to ... Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings Michael Carter / 27 March 2012 The rollout of antiretroviral therapy in resource-limited settings provides a model for efforts to increase access to hepatitis C treatment and care in similar settings, investigators argue in the online edition of Clinical ... Hepatitis C protease inhibitor therapy cost-effective in some circumstances Michael Carter / 21 February 2012 First-line hepatitis C therapy which includes a protease inhibitor can be cost-effective, investigators show in the Annals of Internal Medicine. The study showed that a triple combination of drugs, including the cheaper ... With special training, effective and safe hepatitis C therapy can be provided in primary care Michael Carter / 23 June 2011 Specially trained primary care providers can offer effective and safe treatment for hepatitis C infection, US investigators report in the New England Journal of Medicine. Rates of sustained virological response were the ... ← Prev1...7879808182Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive